All Type of News
Daewoong launching Ursa’s new campaign
Daewoong Pharmaceutical said Monday it has launched a new advertising campaign promoting the efficacy of Ursa, the best-selling hepatic function medicine here.
The new advertising campaign for Ursa is designed to c...
Oriental medical professors calls for oriental medicines to be covered by health insurance
People will be more easily able to buy inexpensive Oriental medicines as the government and the Association of Korean Oriental Medicine will push ahead with a plan to test-run oriental medicines, which will be covered...
Korean drug makers still stuck in quagmire
Korean pharmaceutical companies are feeling pains from all sides. Relying too much on selling cheap generic drugs instead of developing original drugs, they lack competitiveness to take on global players.
On its p...
Chong Kun Dang seeks overseas expansion
Chong Kun Dang Pharmaceutical is aiming to go global with rosuvastain, a member of the drug class of statins.
The company on Thursday said in its regulatory filing that its rosuvastatin patent has received the gree...
Dispute over generic dispensing rekindled
Dispute has erupted recently between doctors and pharmacists over who gets the right to prescribe generic drugs to patients.
The controversy came as the Korean Pharmaceutical Association (KPA) sent its official let...
Hanbul Pharm goes bankrupt
Hanbul Pharmaceutical, the country’s mid-sized drug maker in terms of sales, was declared bankrupt Wednesday after failing to honor commercial papers, sending out shocking signals to local wholesalers.
The company,...
Pharmacists blast doctors’ claim over in-hospital drug dispensing for outpatients
The Korean Pharmaceutical Association (KPA) strongly denounced doctors renewing their claim to in-hospital drug dispensing for outpatients in the midst of strained bilateral ties.
“We request that a related claim ...
Government to overhaul price evaluation system
The National Health Insurance Corporation (NHIC) plans to make public the establishment of a separate committee aiming to enhance the transparency of insurance price evaluation with drug companies.
So far, the NHIC...
KPMA seeking to change ”generic” to other name
The Korea Pharmaceutical Manufacturers Association (KPMA) is considering changing “generic drug” to other appropriate name in an effort to dispel general public’s negative image
In a board of directors meeting on ...
Drug price reform decreases Koreans’ spending on medication by 440 billion won in 2012
The Ministry of Health and Welfare said Wednesday that the government-mandated price cut measures contributed to slashing the country’s spending on medication by 437 billion won last year.
According to the ministry...
